Speaker illustration

Doctor Keiichi Tsuchida

Niigata City General Hospital, Niigata (Japan)

A possible link between sarcopenia and major bleeding risk among patients with atrial fibrillation treated with oral anticoagulation undergoing coronary stenting

Event: ESC Asia with APSC & AFC

Topic: Oral Anticoagulation

Session: Poster Session 1

Thumbnail

Ten-year outcomes following coronary revascularization in patients with impaired glucose tolerance

Event: ESC Congress 2018

Topic: Diabetes and the Heart, Other

Session: Diabetes, obesity and metabolic syndrome

Thumbnail

The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy

Event: ESC Congress 2018

Topic: Anticoagulants

Session: Optimal surrogate endpoints of drug response

Thumbnail

Cystatin C-based estimated glomerular filtration rate to predict diuretic response to tolvaptan in acute decompensated heart failure

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: New aspects of heart failure treatment

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb